MaaT Pharma Presents the ARES Phase 3 Pivotal Trial Final Data During the Presidential Plenary Session at the 52nd Annual Meeting of the European Society for Bone and Marrow Transplantation
· maat pharma – investor relations
AI Briefing
- MaaT Pharma presents ARES Phase 3 trial data
- Final data from pivotal trial presented at EBMT annual meeting
- MaaT Pharma to share ARES Phase 3 trial results
Advertisement